International Briefs: NICE On Sutureless Aortic Valves, Mechanical Clot Retrieval, Microsphere Cancer Therapy
This article was originally published in The Gray Sheet
Executive Summary
In recent guidance documents, the U.K.’s National Institute for Health and Care Excellence offers tempered support for sutureless aortic valve replacement, and calls mechanical clot retrieval in stroke patients unproven and risky. Also, its support for radioactive microspheres for liver cancer depends on malignancy type.
You may also be interested in...
Research In Brief
Data preview for Heart Rhythm Society conference in Denver this week. More research news.
Neurointerventional Device Update: The Burgeoning Stroke Toolbox
The treatment of acute ischemic stroke and brain aneurysms is rapidly evolving. New transcatheter devices and adjuvant imaging promising to improve outcomes and reduce the burden of neurovascular disease. However, to really spur this market, long-term, large-scale clinical trials are needed.
Finance Watch: Karuna, Cerevel And Others Benefit From Improving Biotech Sentiment
Good news in the biopharma industry and the US economy gave public drug developers the boost they needed to raise cash, including Karuna’s $750m offering. Private company financings slowed during the second week of August, but Prellis and Vector BioPharma raised venture capital.